<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JPP</journal-id>
<journal-id journal-id-type="hwp">spjpp</journal-id>
<journal-title>Journal of Pharmacy Practice</journal-title>
<issn pub-type="ppub">0897-1900</issn>
<issn pub-type="epub">1531-1937</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0897190012452310</article-id>
<article-id pub-id-type="publisher-id">10.1177_0897190012452310</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Adverse Drug Events</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Eosinophilic Meningitis Secondary to Intravenous Vancomycin</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kazi</surname>
<given-names>Ruchika</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0897190012452310">1</xref>
<xref ref-type="corresp" rid="corresp1-0897190012452310"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kazi</surname>
<given-names>Haseeb A.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0897190012452310">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ruggeri</surname>
<given-names>Cara</given-names>
</name>
<degrees>DO</degrees>
<xref ref-type="aff" rid="aff1-0897190012452310">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ender</surname>
<given-names>Peter T.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0897190012452310">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-0897190012452310">
<label>1</label>Department of Internal Medicine, St. Luke’s University Hospital, Bethlehem, PA, USA</aff>
<aff id="aff2-0897190012452310">
<label>2</label>Section of Infectious Diseases, St. Luke’s University Hospital, Bethlehem, PA, USA</aff>
<author-notes>
<corresp id="corresp1-0897190012452310">Ruchika Kazi, Department of Internal Medicine, St. Luke’s University Hospital, 801 Ostrum St., Bethlehem, PA 18015, USA. Email: <email>kazir@slhn.org</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2013</year>
</pub-date>
<volume>26</volume>
<issue>3</issue>
<issue-title>Pharmacy Practice I</issue-title>
<fpage>261</fpage>
<lpage>263</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Eosinophilic meningitis may be due to infectious or noninfectious etiologies. Parasitic infections cause this entity most frequently and of the noninfectious causes, medications play an important role. We describe a 32-year-old male who developed eosinophilic meningitis while receiving intravenous vancomycin. No other apparent cause of the eosinophilic meningitis was appreciated. This case represents the first description of eosinophilic meningitis due to systemic vancomycin.</p>
</abstract>
<kwd-group>
<kwd>infectious disease</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0897190012452310">
<title>Introduction</title>
<p>Eosinophilic meningitis is a rare condition caused by both infections and noninfectious etiologies. In this illness, meningeal inflammation presumably occurs in a fashion similar to other forms of meningitis. Clinical manifestations may include stiff neck, headache, confusion, fever, chills, nausea, vomiting, or seizures. As with other forms of meningitis, cerebrospinal fluid (CSF) analysis is needed to confirm the presence of this condition. The diagnosis of this entity requires the presence of at least 10 eosinophils/μL in the CSF and/or at least 10% of the leukocytes in the CSF being eosinophils.<sup>
<xref ref-type="bibr" rid="bibr1-0897190012452310">1</xref>
</sup>
</p>
<p>Parasitic infections, such as <italic>Angiostrongylus cantonensis</italic>, <italic>Baylisascariasis</italic> species, and <italic>Gnathostomiasis</italic> species are the most prominent of the infectious etiologies. Noninfectious etiologies may include sarcoidosis, malignancy, such as leukemia or lymphoma, and most prominently, medications.<sup>
<xref ref-type="bibr" rid="bibr1-0897190012452310">1</xref>,<xref ref-type="bibr" rid="bibr2-0897190012452310">2</xref>
</sup> Eosinophilic meningitis has been associated with the use of beta-lactams, gentamicin, ciprofloxacin, ibuprofen, and intrathecal vancomycin.<sup>
<xref ref-type="bibr" rid="bibr3-0897190012452310">3</xref>
<xref ref-type="bibr" rid="bibr4-0897190012452310"/>
<xref ref-type="bibr" rid="bibr5-0897190012452310"/>
<xref ref-type="bibr" rid="bibr6-0897190012452310"/>–<xref ref-type="bibr" rid="bibr7-0897190012452310">7</xref>
</sup> It has never been associated with intravenous vancomycin use. We report the first described case of eosinophilic meningitis secondary to intravenous vancomycin.</p>
<sec id="section2-0897190012452310">
<title>Case Presentation</title>
<p>A 32-year-old male developed fever of 39.1°C, vomiting, weakness, anorexia, headache, and posterior occipital tenderness. The patient had a history of asthma, type 2 diabetes mellitus, anxiety and depression, and had not been on any immunosuppressive treatment in the recent past. His home medications included pioglitazone, rosuvastatin, montelukast, and inhaled budesonide/formoterol. The patient had no known risk factors for parasitic causes of eosinophilic meningitis, such as ingestion of raw snails or slugs or travel to areas endemic for these infections.</p>
<p>He had recently undergone decompression of a cervicle syrinx that was complicating a Chairi I malformation. In the perioperative period, he had a lumbar drain placed, which was complicated in the postoperative period by a pseudomeningocele requiring repair. He developed fever and worsening headache and was eventually diagnosed with <italic>Staphylococcus epidermis</italic> meningitis based upon CSF gram stain and culture obtained from the lumbar drain. The patient was started on intravenous vancomycin and the lumbar drain was removed. He clinically improved with resolution of his headache and was discharged home to complete a 14-day course of intravenous vancomycin via a peripherally inserted central catheter (PICC).</p>
<p>While on the intravenous vancomycin at home, he developed the above described fever, vomiting, weakness, anorexia, headaches, and occipital tenderness and was admitted for further evaluation. His initial temperature was 38.3°C, with a healing occipital incision site. There was no nuchal rigidity and his skin examination was normal. Initial leukocyte count was 6.59 × 10<sup>3</sup>/dL and serum creatinine was 2.1 mg/dL. The vancomycin was discontinued, the PICC was removed, and the patient underwent a lumbar puncture. CSF analysis revealed eosinophilic pleocytosis with 84% eosinophils (<xref ref-type="table" rid="table1-0897190012452310">Table 1</xref>). Examination of the CSF for parasites was negative. Blood and venous catheter cultures were negative and culture of the spinal fluid grew no bacteria. Additional CSF was obtained via lumbar puncture on days 2, 3, 7, and 8 to confirm clearance of the meningitis with discontinuation of the vancomycin (<xref ref-type="table" rid="table1-0897190012452310">Table 1</xref>). After discontinuation of the vancomycin, his CSF eosinophilia and clinical meningitis rapidly resolved. None of the other medications he was taking at home were discontinued, as his symptoms resolved with discontinuation of the intravenous vancomycin.</p>
<table-wrap id="table1-0897190012452310" position="float">
<label>Table 1.</label>
<caption>
<p>CSF Studies.<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table1-0897190012452310" xlink:href="10.1177_0897190012452310-table1.tif"/>
<table>
<thead>
<tr>
<th>Day</th>
<th>Glucose, mg/dL</th>
<th>Protein, mg/dL</th>
<th>RBC</th>
<th>WBC, per μL</th>
<th>Segs, %</th>
<th>Lymphocytes, %</th>
<th>Monocytes, %</th>
<th>Eosinophils, %</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>10</td>
<td>104</td>
<td>142</td>
<td>141</td>
<td>0</td>
<td>11</td>
<td>5</td>
<td>84</td>
</tr>
<tr>
<td>2</td>
<td>6</td>
<td>122</td>
<td>1200</td>
<td>133</td>
<td>0</td>
<td>33</td>
<td>5</td>
<td>62</td>
</tr>
<tr>
<td>3</td>
<td>24</td>
<td>111</td>
<td>69</td>
<td>116</td>
<td>0</td>
<td>25</td>
<td>11</td>
<td>64</td>
</tr>
<tr>
<td>7</td>
<td>40</td>
<td>95</td>
<td>66</td>
<td>66</td>
<td>0</td>
<td>57</td>
<td>8</td>
<td>35</td>
</tr>
<tr>
<td>8</td>
<td>64</td>
<td>249</td>
<td>16 060</td>
<td>99</td>
<td>67</td>
<td>25</td>
<td>2</td>
<td>4</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0897190012452310">
<p>Abbreviations: CSF, cerebrospinal fluid; RBC, red blood cell; Segs, Segmented neutrophils; WBC, white blood cell.</p>
</fn>
<fn id="table-fn2-0897190012452310">
<p>
<sup>a</sup> CSF eosinophilia trended down after discontinuation of intravenous vancomycin.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section3-0897190012452310">
<title>Discussion</title>
<p>Eosinophilic meningitis can be caused by both infectious and noninfectious etiologies and the most common noninfectious causes include neoplastic diseases and medications. While eosinophilic meningitis has been reported with intrathecal vancomycin, it has not previously been reported with intravenous vancomycin.<sup>
<xref ref-type="bibr" rid="bibr7-0897190012452310">7</xref>
</sup> This patient appears to have suffered from eosinophilic meningitis secondary to intravenous vancomycin. His symptoms developed while on intravenous vancomycin and these symptoms as well as the CSF eosinophilia resolved rapidly with discontinuation of this antimicrobial. As with other cases of medication-induced meningitis, the primary treatment approach to this patient was discontinuation of the offending agent. The appropriate treatment of other forms of eosinophilic meningitis depends upon the cause. For example, meningitis caused by parasitic agents is often treated with antihelminthics, and malignancy is usually treated with chemotherapeutic agents directed at the specific malignancy.</p>
<p>As CSF cell counts were not obtained prior to the use of vancomycin, one could argue that this abnormality may have been present prior to the vancomycin use. However, bacterial meningitis due to <italic>Staphylococcus epidermidis</italic> would not be expected to cause this type of CSF aberration. While CSF eosinophilia has been reported with ventriculoperitoneal shunt placement, ventriculostomy, and meningeal cystectomy, it has not been reported to be caused by other types of central nervous system surgery. <sup>
<xref ref-type="bibr" rid="bibr8-0897190012452310">8</xref>
<xref ref-type="bibr" rid="bibr9-0897190012452310"/>–<xref ref-type="bibr" rid="bibr10-0897190012452310">10</xref>
</sup> No other infectious or noninfectious etiology was found to explain the eosinophilic meningitis.</p>
<p>The specific pathophysiology of medication-induced eosinophilic meningitis is unknown. It is also unclear whether vancomycin-induced eosinophilic meningitis has a similar causative etiology to other types of medication-induced eosinophilic meningitis. Intrathecal synthesis of immunoglobulins has been reported from parasite-induced eosinophilic meningitis, particularly immunoglobulin E.<sup>
<xref ref-type="bibr" rid="bibr11-0897190012452310">11</xref>,<xref ref-type="bibr" rid="bibr12-0897190012452310">12</xref>
</sup> Of the possible mechanisms of medication-induced eosinophilic meningitis, a hypersensitivity reaction appears most likely. In this case, the onset of illness occurred after 10 days of intravenous vancomycin, suggesting the possibility of a delayed-type hypersensitivity. Study of this complication of vancomycin use is difficult due to the rarity of eosinophilic meningitis. CSF analysis of the inflammatory response during this illness could help better understand the pathophysiology of this entity.</p>
<p>In summary, we report a case of eosinophilic meningitis due to intravenous vancomycin. No other clear source of this meningitis could be found and the clinical and CSF abnormalities rapidly resolved with discontinuation of the vancomycin.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-0897190012452310">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0897190012452310">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0897190012452310">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lo Re</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gluckman</surname>
<given-names>SJ</given-names>
</name>
</person-group>. <article-title>Eosinophilic meningitis</article-title>. <source>Am J Med</source>. <year>2003</year>;<volume>114</volume>:<fpage>217</fpage>–<lpage>223</lpage>.</citation>
</ref>
<ref id="bibr2-0897190012452310">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramirez-Avila</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Slome</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schuster</surname>
<given-names>FL</given-names>
</name>
<etal/>
</person-group> <article-title>Eosinophilic meningitis due to <italic>Angiostrongylus </italic>and <italic>Gnathostoma </italic>species</article-title>. <source>Clin Infect Dis</source>. <year>2009</year>:<volume>48</volume>:<fpage>322</fpage>–<lpage>327</lpage>.</citation>
</ref>
<ref id="bibr3-0897190012452310">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>River</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Averbuch-Heller</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Weinberger</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Antibiotic induced meningitis</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. <year>1994</year>;<volume>57</volume>(<issue>6</issue>):<fpage>705</fpage>–<lpage>708</lpage>.</citation>
</ref>
<ref id="bibr4-0897190012452310">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mine</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yamaura</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Eosinophilia of the cerebrospinal fluid in a case of shunt infection: case report</article-title>. <source>Neurosurgery</source>. <year>1986</year>;<volume>19</volume>(<issue>5</issue>):<fpage>835</fpage>–<lpage>836</lpage>.</citation>
</ref>
<ref id="bibr5-0897190012452310">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asperilla</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Smego</surname>
<given-names>RA</given-names>
<suffix>Jr</suffix>
</name>
</person-group>. <article-title>Eosinophilic meningitis associated with ciprofloxacin</article-title>. <source>Am J Med</source>. <year>1989</year>;<volume>87</volume>(<issue>5</issue>):<fpage>589</fpage>–<lpage>590</lpage>.</citation>
</ref>
<ref id="bibr6-0897190012452310">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quinn</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Weinstein</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Caplan</surname>
<given-names>LR</given-names>
</name>
</person-group>. <article-title>Eosinophilic meningitis and ibuprofen therapy</article-title>. <source>Neurology</source>. <year>1984</year>;<volume>34</volume>(<issue>1</issue>):<fpage>108</fpage>–<lpage>109</lpage>.</citation>
</ref>
<ref id="bibr7-0897190012452310">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grabb</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Albright</surname>
<given-names>AL</given-names>
</name>
</person-group>. <article-title>Intraventricular vancomycin-induced cerebrospinal fluid eosinophilia: report of two patients</article-title>. <source>Neurosurgery</source>. <year>1992</year>;<volume>30</volume>:<fpage>630</fpage>–<lpage>635</lpage>.</citation>
</ref>
<ref id="bibr8-0897190012452310">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tung</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Raffel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>McComb</surname>
<given-names>JG</given-names>
</name>
</person-group>. <article-title>Ventricular cerebrospinal fluid eosinophilia in children with ventriculoperitoneal shunts</article-title>. <source>J Neurosurg</source>. <year>1991</year>;<volume>75</volume>(<issue>4</issue>):<fpage>541</fpage>–<lpage>544</lpage>.</citation>
</ref>
<ref id="bibr9-0897190012452310">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bell</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Vo</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>PB</given-names>
</name>
<etal/>
</person-group> <article-title>Eosinophilic meningitis after implantation of a rifampin and minocycline-impregnated ventriculostomy catheter in a child. Case report</article-title>. <source>J Neurosurg</source>. <year>2006</year>;<volume>104</volume>(<issue>1 suppl</issue>):<fpage>50</fpage>–<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr10-0897190012452310">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bottieau</surname>
<given-names>E</given-names>
</name>
<name>
<surname>David</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dewitte</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group> <article-title>Eosinophilic meningitis following incomplete resection of a meningeal hydatid cyst</article-title>. <source>Scand J Infect Dis</source>. <year>2003</year>;<volume>35</volume>(<issue>11-12</issue>):<fpage>898</fpage>–<lpage>901</lpage>.</citation>
</ref>
<ref id="bibr11-0897190012452310">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dorta-Contreras</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Reiber</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Intrathecal synthesis of immunoglobulins in eosinophilic meningoencephalitis due to <italic>Angiostrongylus cantonensis</italic>
</article-title>. <source>Clin Diagn Lab Immunol</source>. <year>1998</year>;<volume>5</volume>(<issue>4</issue>):<fpage>452</fpage>–<lpage>455</lpage>.</citation>
</ref>
<ref id="bibr12-0897190012452310">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Padilla-Docal</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dorta-Contreras</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Bu-Coifiu-Fanego</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>Intrathecal synthesis of IgE in children with eosinophilic meningoencephalitis caused by <italic>Angiostrongylus cantonensis</italic>
</article-title>. <source>Cerebrospinal Fluid Res</source>. <year>2008</year>;<volume>5</volume>:<fpage>18</fpage>.</citation>
</ref>
</ref-list>
</back>
</article>